← Back to Search

N/A

Almonds for Obesity (SNACKing Trial)

N/A
Waitlist Available
Led By Hannah D Holscher, PhD RD
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline & 12-week mark
Awards & highlights

Summary

This trial will study the effects of almond consumption on gut bacteria and metabolism.

Eligible Conditions
  • Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline & 12-week mark
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline & 12-week mark for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes in abundance of fecal Butyryl CoA: Acetate CoA transferase
Changes in abundance of fecal Roseburia spp
Changes in gastrointestinal microbial-derived metabolite concentrations
+1 more
Secondary study objectives
Changes in glycemic control.
Changes in liver fat
Changes in secondary measures of gastrointestinal health.
Other study objectives
Changes in adiposity.
Changes in markers of systemic inflammation & metabolism
Changes in subjective measures of gastrointestinal health.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionExperimental Treatment1 Intervention
The intervention arm consists of daily consumption of the investigator's intervention snack over the course of 12 weeks.
Group II: Isocaloric ControlPlacebo Group1 Intervention
The control arm consists of daily consumption of an isocaloric snack over the course of 12 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Almonds
2008
Completed Phase 4
~730

Find a Location

Who is running the clinical trial?

University of Illinois at Urbana-ChampaignLead Sponsor
196 Previous Clinical Trials
38,119 Total Patients Enrolled
23 Trials studying Obesity
2,490 Patients Enrolled for Obesity
Almond Board of CaliforniaOTHER
34 Previous Clinical Trials
2,137 Total Patients Enrolled
7 Trials studying Obesity
439 Patients Enrolled for Obesity
Hannah D Holscher, PhD RDPrincipal InvestigatorUniversity of Illinois at Urbana-Champaign
1 Previous Clinical Trials
200 Total Patients Enrolled
~15 spots leftby Sep 2025